Abbisko Therapeutics Co. Ltd. on Wednesday entered into a strategic collaboration with AstraZeneca Plc AZN to jointly develop ...
AstraZeneca has signed a strategic collaboration agreement with Abbisko Therapeutics to study the combined use of Tagrisso ...
AstraZeneca has impressed oncology patient groups, rising to second place on PatientView’s corporate reputation ranking on the back of strength in breast and lung cancer. | AstraZeneca has impressed ...
Abbisko Therapeutics Co., Ltd. ('Abbisko Therapeutics' hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN) ...
AstraZeneca (LSE:AZN) secured European Union approval for Enhertu as the first HER2-directed antibody drug conjugate with a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The AstraZeneca patient spending ...
AstraZeneca will pay $34 million to resolve a lawsuit that alleged the company used illegal kickbacks to induce providers to ...
Additional clinical and real-world data from the industry’s largest and broadest amyloidosis pipeline will advance understanding of underlying mechanisms of disease and unmet needs Christophe ...
Health and Me on MSN
Could chemotherapy soon be optional? AstraZeneca and Gilead drugs show promise for breast cancer patients
Clinical trials showed that both Datroway, developed by AstraZeneca in partnership with Daiichi Sankyo, and Trodelvy from ...
AstraZeneca India aims to accelerate innovation and clinical trials, enhancing access to life-saving medicines for patients.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results